Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren P Mason

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
Journal of Cognitive Neuroscience|May 14, 2011
Right frontal lobe mediation of recollection- and familiarity-based verbal recognition memory: evidence from patients with tumor resectionsNicole D Anderson, Patrick S R Davidson, Warren P Mason, et al.
Neurology|October 14, 2022
Opinion & Special Article: Glioma Classification: How to Interpret Molecular Markers in a Diffuse Glioma Pathology ReportMatthijs van der Meulen, Ronald C Ramos, Warren P Mason, et al.
Cancer Immunology Research|October 1, 2015
Subacute CNS Demyelination after Treatment with Nivolumab for MelanomaCatherine Maurice, Raphael Schneider, Tim-Rasmus Kiehl, et al.
Journal of Neuroimmunology|July 2, 2020
Guillain-Barré Syndrome following a series of novel therapies adapting the gold-standard in the era of immune primingCatherine Maurice, Leila Khoja, Erin Morgan, et al.
Journal of Neuro-Oncology|November 4, 2011
A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progressionWarren P Mason, Karl Belanger, Garth Nicholas, et al.
Journal of Neuro-Oncology|January 29, 2014
Conditional probability of survival and post-progression survival in patients with glioblastoma in the temozolomide treatment eraMairéad G McNamara, Zarnie Lwin, Haiyan Jiang, et al.
Journal of Neuro-Oncology|August 28, 2013
Glioblastoma management in the temozolomide era: have we improved outcome?Zarnie Lwin, Derek MacFadden, Ahmed Al-Zahrani, et al.
Investigational New Drugs|December 14, 2011
A phase I study of temozolomide and everolimus (RAD001) in patients with newly diagnosed and progressive glioblastoma either receiving or not receiving enzyme-inducing anticonvulsants: an NCIC CTG studyWarren P Mason, Mary Macneil, Petr Kavan, et al.
The Oncologist|February 16, 2006
Changing paradigms--an update on the multidisciplinary management of malignant gliomaRoger Stupp, Monika E Hegi, Martin J van den Bent, et al.
Archives of Neurology|October 14, 2009
Polymyoclonus, laryngospasm, and cerebellar ataxia associated with adenocarcinoma and multiple neural cation channel autoantibodiesShen-Yang Lim, Warren P Mason, Nathan P Young, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
Journal of Cognitive Neuroscience|May 14, 2011
Right frontal lobe mediation of recollection- and familiarity-based verbal recognition memory: evidence from patients with tumor resectionsNicole D Anderson, Patrick S R Davidson, Warren P Mason, et al.
Neurology|October 14, 2022
Opinion & Special Article: Glioma Classification: How to Interpret Molecular Markers in a Diffuse Glioma Pathology ReportMatthijs van der Meulen, Ronald C Ramos, Warren P Mason, et al.
Cancer Immunology Research|October 1, 2015
Subacute CNS Demyelination after Treatment with Nivolumab for MelanomaCatherine Maurice, Raphael Schneider, Tim-Rasmus Kiehl, et al.
Journal of Neuroimmunology|July 2, 2020
Guillain-Barré Syndrome following a series of novel therapies adapting the gold-standard in the era of immune primingCatherine Maurice, Leila Khoja, Erin Morgan, et al.
Journal of Neuro-Oncology|November 4, 2011
A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progressionWarren P Mason, Karl Belanger, Garth Nicholas, et al.
Journal of Neuro-Oncology|January 29, 2014
Conditional probability of survival and post-progression survival in patients with glioblastoma in the temozolomide treatment eraMairéad G McNamara, Zarnie Lwin, Haiyan Jiang, et al.
Journal of Neuro-Oncology|August 28, 2013
Glioblastoma management in the temozolomide era: have we improved outcome?Zarnie Lwin, Derek MacFadden, Ahmed Al-Zahrani, et al.
Investigational New Drugs|December 14, 2011
A phase I study of temozolomide and everolimus (RAD001) in patients with newly diagnosed and progressive glioblastoma either receiving or not receiving enzyme-inducing anticonvulsants: an NCIC CTG studyWarren P Mason, Mary Macneil, Petr Kavan, et al.
The Oncologist|February 16, 2006
Changing paradigms--an update on the multidisciplinary management of malignant gliomaRoger Stupp, Monika E Hegi, Martin J van den Bent, et al.
Archives of Neurology|October 14, 2009
Polymyoclonus, laryngospasm, and cerebellar ataxia associated with adenocarcinoma and multiple neural cation channel autoantibodiesShen-Yang Lim, Warren P Mason, Nathan P Young, et al.
Pageof 12